News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
HST Global, Inc. Announces Details of Protocol Licensing for Health Matters International
May 4, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
HAMPTON, Va.--(BUSINESS WIRE)--HST Global, Inc. (OTCBB: HSTC) today announced that it has formalized the licensing details for Health Matters International.
Twitter
LinkedIn
Facebook
Email
Print
Alliances
MORE ON THIS TOPIC
Layoffs
InflaRx Stanches Spending With 30% Staff Reduction, Priority Pivot
January 9, 2026
·
1 min read
·
Tristan Manalac
Mergers & acquisitions
Revolution Soars Amid Swirling Buyout Rumors With Merck, AbbVie
January 9, 2026
·
1 min read
·
Tristan Manalac
Layoff Tracker
Tessera Trimming 90 Employees as Part of Pipeline Prioritization
January 8, 2026
·
99 min read
·
BioSpace Editorial Staff
Venture capital
Parabilis Heads Biotech Fundraising Frenzy With $305M to Advance Cancer Drug
January 8, 2026
·
2 min read
·
Tristan Manalac
